TY - JOUR KW - Clofazimine KW - Drug Therapy, Combination KW - Humans KW - Indian Ocean Islands KW - Isoniazid KW - leprosy KW - Rifampin AU - Cnudde F AU - Julvez J AU - Rivière J P AB -

Leprosy in Mayotte affects 480 persons in a population of 80,000 inhabitants. 229 patients have been treated every day by association of Rifampicin, Clofazimine and Isoniazide. This study make a clinical, histological and bacteriological valuation after treatment, during a period of 3 years. With paucibacillary patients, whom received 1 year of mean treatment and after 2 years under observation, histology for short-dated can stay positive and active. With multibacillary patients, whom received 26 months of mean treatment and most of the time after 1 year under observation, the all of morphological index is negative, sometime bacteriology is positive, less often than histology. For middle- and long-dated, histology should allow a good valuation for disease evolution, specially for interpolar leprosy patients.

BT - Acta leprologica C1 - http://www.ncbi.nlm.nih.gov/pubmed/3303804?dopt=Abstract DA - 1987 Apr-Jun IS - 2 J2 - Acta Leprol LA - fre N2 -

Leprosy in Mayotte affects 480 persons in a population of 80,000 inhabitants. 229 patients have been treated every day by association of Rifampicin, Clofazimine and Isoniazide. This study make a clinical, histological and bacteriological valuation after treatment, during a period of 3 years. With paucibacillary patients, whom received 1 year of mean treatment and after 2 years under observation, histology for short-dated can stay positive and active. With multibacillary patients, whom received 26 months of mean treatment and most of the time after 1 year under observation, the all of morphological index is negative, sometime bacteriology is positive, less often than histology. For middle- and long-dated, histology should allow a good valuation for disease evolution, specially for interpolar leprosy patients.

PY - 1987 SP - 115 EP - 24 T2 - Acta leprologica TI - [Short-term clinical and histological evaluation of combination drug therapy of leprosy in Mayotte]. VL - 5 SN - 0001-5938 ER -